Drug intelligence / Profile preview

alpha-synuclein A53T AAV

Development stage
Preclinical
Lead developer
GeneDetect
Modality
Viral Vectors → Gene Addition/Replacement → Gene Therapies
Administration
Intracerebral
01

Overview

Alpha-synuclein A53T AAV is an adeno-associated viral (AAV) vector used primarily in preclinical research to model Parkinson's disease. It delivers the human SNCA gene carrying the A53T missense mutation, which is associated with early-onset familial Parkinson's disease. Upon stereotaxic injection into specific brain regions like the substantia nigra pars compacta (SNpc), the vector induces the overexpression of mutant alpha-synuclein, leading to protein aggregation, dopaminergic neuronal loss, and mitochondrial dysfunction. This model is essential for investigating the molecular mechanisms of synucleinopathies and evaluating potential therapeutic interventions.

Other names
A53T alpha-synuclein adeno-associated virusA-53T alpha-synuclein adeno-associated virusA 53T alpha-synuclein adeno-associated virusAAV-A53T-alpha-synuclein expression vectorAAV-A-53T-alpha-synuclein expression vectorAAV-A 53T-alpha-synuclein expression vector
02

Targets

SNCA (Alpha-synuclein)

Beyond the preview

Go deeper on alpha-synuclein A53T AAV.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-synuclein A53T AAV.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call